Polyclonal antibodies against APOH and MGAM in Behçet’s disease (BD) and Crohn’s disease (CD) research

June, 2021 (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea)

A new open-access study published on Scientific Reports searches for candidates biomarker to differentiate intestinal Behçet’s disease (BD) from Crohn’s disease (CD).

Our polyclonal antibodies against APOH (HPA003732) and MGAM (HPA002270) were used on formalin-fixed paraffin-embedded colonic biopsy sections from patients with intestinal BD and CD.

Proteomic analysis revealed that some proteins were differentially expressed in patients with intestinal BD than those with CD. Differential MGAM expression in intestinal BD suggests its role as a potential novel diagnostic biomarker.

Read more: https://lnkd.in/drd3FAN

The image shows APOH (HPA003732) and MGAM (HPA002270) expression in the colonic mucosa.